New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. The appointments add experienced leaders to Illumina's Executive Leadership [...]

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production. The new SEC and PLRP-S columns support critical analytical workflows across a [...]

Advancing Scalable Reproducible Cell Therapy and Advanced Cell Culture Workflows New heat-stable and hyperactive proteins across the fibroblast growth factor and interleukin cytokine families expand the R&D Systems™ AI-Engineered Designer Protein portfolio AI-guided protein design supports improved consistency, performance and scalability in complex cell culture workflows Engineered signaling proteins help address key challenges in scaling [...]

Melbourne, Australia, and Oxford, UK – Victorian Clinical Genetics Services (“VCGS”) has received National Association of Testing Authorities (NATA) accreditation to ISO 15189 for a clinical whole genome sequencing workflow incorporating Oxford Nanopore sequencing technology. Whole human genome sequencing provides a comprehensive view of a person’s DNA, generating richer genetic information that can help clinicians characterise [...]

Partnership pairs Applied StemCell's induced pluripotent stem cell technology with RoosterBio's engineered media, reagents, and scalable bioprocess systems to accelerate development and manufacturing of advanced therapies MILPITAS, Calif. and FREDERICK, Md. -- Applied StemCell, Inc. ("ASC"), a biotechnology company with deep expertise and intellectual property in induced pluripotent stem cell (iPSC) technology, and RoosterBio, Inc., [...]

Partnership pairs GMP-manufactured iPSC lines with matched RUO equivalents, giving developers well-characterized, donor-eligible starting materials from early research through clinical development. Supporting comparability data for the RUO and GMP lines to be presented at the 2026 ISSCR Annual Meeting in Montréal, Canada. VANCOUVER, British Columbia & TORONTO -- STEMCELL Technologies and the Centre for Commercialization [...]

Scientifica is pleased to announce the launch of PatchPad Evo, a next-generation electrophysiology controller that enables intuitive control of multiple Scientifica motorised devices from a single, compact unit. Featuring an integrated display with real-time XYZ coordinates, PatchPad Evo brings essential information directly to the controller, allowing researchers to work from a single, focused interface with [...]

Collaboration pairs PerkinElmer's ICP-MS/MS and LC-MS/MS technologies with Covalent's failure analysis expertise to help manufacturers pinpoint the root causes of material failure and performance degradation. SHELTON, Conn. and SUNNYVALE, Calif. -- PerkinElmer and Covalent today announced a strategic collaboration to provide advanced analytical instrumentation and analysis services that address the growing complexity of failure analysis [...]

Approval of the Applied Biosystems™ RapidINTEL™ Plus Cartridge enables qualifying crime scene DNA profiles generated on the RapidHIT ID™ System to be searched against the national CODIS database network KEY FACTS Product: Applied Biosystems™ RapidINTEL™ Plus Cartridge used with the Applied Biosystems™ RapidHIT ID™ System Category: Rapid DNA forensic analysis solution Key benefit: Enables qualifying [...]

New capabilities unify Certara's biosimulation software, products, datasets, and scientific expertise with AI-driven agents to deliver specialized insights for life sciences RADNOR, Pa. -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, is partnering with NVIDIA to advance Certara's open integrated AI platform, unifying its scientific software, regulatory expertise, and proprietary datasets [...]